NCT01036633
- Conditions
- Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +5 more
- Locations
-
Not specified
Clinical trial condition
Gastroenteritis
Explore clinical trials studying Gastroenteritis. Study availability and eligibility vary by location and protocol.
3,766 public trials
673 recruiting studies
Gastroenteritis trial results
Completed
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
NCT01040598
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- O & O Alpan LLC Springfield, Virginia, United States
Completed
A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease
NCT00072943
- Conditions
- Colitis, Colonic Diseases, Crohn Disease, +9 more
- Locations
-
- Advanced Clinical Research Institute Anaheim, California, United States
- Doctor's Office Orange, California, United States
- Gainesville VA Medical Center Gainesville, Florida, United States
- Waterside Clinical Research Services, Inc. West Palm Beach, Florida, United States
NCT00267306
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
- Locations
-
- Inflammatory Bowel Disease Center Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- Atlanta Gastroenterology Associates Atlanta, Georgia, United States
- Northwestern University Chicago, Illinois, United States
NCT00267709
- Conditions
- Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
- Locations
-
- Mayo Clinic Rochester Rochester, Minnesota, United States
NCT00032305
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California San Francisco, California, United States
- Atlanta Gastroenterology Associates Atlanta, Georgia, United States
- The University of Chicago Medical Center Chicago, Illinois, United States
Completed
Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease
NCT00267722
- Conditions
- Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
- Locations
-
- Inflammatory Bowel Disease Center Los Angeles, California, United States
- Mount Sinai School of Medicine New York, United States
Completed
Mind/Body Medicine and IBD Flare-Up
NCT00568256
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
- Locations
-
- Rush University Medical Center Chicago, Illinois, United States
NCT01538797
- Conditions
- Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
- Locations
-
- Hammersmith Medicines Research London, United Kingdom
NCT01538784
- Conditions
- Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
- Locations
-
- Hammersmith Medicines Research London, United Kingdom